Necrotizing soft-tissue infection
Conditions
Brief summary
30-day all-cause mortality post-randomization
Detailed description
90-day all-cause mortality post-randomization, Amputation (y/n) within 7 days post-randomization, Quality of life at Day 90 evaluated with the 5Q-5D-5L, Quality of life at Day 90 evaluated with the WHO-DAS questionnaire, Days alive and out of hospital in the 90-day period, Ventilator-free days within 7 days post-randomization, Need for renal-replacement therapy (y/n) within 7 days, Number of subjects with one or more serious adverse events up to 24 hours after last treatment
Interventions
DRUGMedical Liquid Oxygen
Sponsors
Rigshospitalet
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 30-day all-cause mortality post-randomization | — |
Secondary
| Measure | Time frame |
|---|---|
| 90-day all-cause mortality post-randomization, Amputation (y/n) within 7 days post-randomization, Quality of life at Day 90 evaluated with the 5Q-5D-5L, Quality of life at Day 90 evaluated with the WHO-DAS questionnaire, Days alive and out of hospital in the 90-day period, Ventilator-free days within 7 days post-randomization, Need for renal-replacement therapy (y/n) within 7 days, Number of subjects with one or more serious adverse events up to 24 hours after last treatment | — |
Countries
Belgium, Denmark, Finland, Norway, Sweden
Outcome results
None listed